Scleroderma - Prognosis

Prognosis

Scleroderma prognosis depends upon the prevailing complications, the type of treatment given, the patient's response to treatment and the effectiveness in monitoring the health status of the patient.


Research has indicated that the patients' risk of organ failure is the highest within the first three years. If three years pass without signs of organ failure then the patient's chances of organ impairment is considerably minimized.

Prognosis for limited cutaneous scleroderma, is rather good.But this does not extend to those with pulmonary arterial hypertension.

5-year survival = 90%

10 year survival =75%

Prognosis is really bad for those with diffuse cutaneous disease, especially if the patient is an older male. Death occurs due to complications from heart and kidney.

5-year survival = 70%,

10-year survival = 55%

Cite this Article ⇣⇡

Please use one of the following formats to cite this article in your essay, paper or report:

• APA

  Dr. Reeja Tharu. (2020, January 13). Scleroderma - Prognosis. Medindia. Retrieved on Dec 03, 2024 from https://www.medindia.net/health/conditions/scleroderma-prognosis.htm.

• MLA

  Dr. Reeja Tharu. "Scleroderma - Prognosis". Medindia. Dec 03, 2024. <https://www.medindia.net/health/conditions/scleroderma-prognosis.htm>.

• Chicago

  Dr. Reeja Tharu. "Scleroderma - Prognosis". Medindia. https://www.medindia.net/health/conditions/scleroderma-prognosis.htm. (accessed Dec 03, 2024).

• Harvard

  Dr. Reeja Tharu. 2020. Scleroderma - Prognosis. Medindia, viewed Dec 03, 2024, https://www.medindia.net/health/conditions/scleroderma-prognosis.htm.